Osaic Holdings’s Seres Therapeutics MCRB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $132 | Buy |
160
+152
| +1,900% | +$125 | ﹤0.01% | 7042 |
|
2025
Q1 | $112 | Sell |
8
-12
| -60% | -$168 | ﹤0.01% | 7044 |
|
2024
Q4 | $335 | Sell |
20
-75
| -79% | -$1.26K | ﹤0.01% | 6924 |
|
2024
Q3 | $1.81K | Sell |
95
-244
| -72% | -$4.65K | ﹤0.01% | 6479 |
|
2024
Q2 | $4.88K | Buy |
339
+314
| +1,256% | +$4.52K | ﹤0.01% | 6075 |
|
2024
Q1 | $389 | Sell |
25
-20,000
| -100% | -$311K | ﹤0.01% | 6683 |
|
2023
Q4 | $561K | Buy |
20,025
+10,308
| +106% | +$289K | ﹤0.01% | 3057 |
|
2023
Q3 | $462K | Buy |
9,717
+258
| +3% | +$12.3K | ﹤0.01% | 3305 |
|
2023
Q2 | $906K | Buy |
9,459
+9,407
| +18,090% | +$901K | ﹤0.01% | 2619 |
|
2023
Q1 | $5.91K | Sell |
52
-15
| -22% | -$1.7K | ﹤0.01% | 6196 |
|
2022
Q4 | $7K | Sell |
67
-162
| -71% | -$16.9K | ﹤0.01% | 6106 |
|
2022
Q3 | $29K | Buy |
229
+177
| +340% | +$22.4K | ﹤0.01% | 5309 |
|
2022
Q2 | $3K | Buy |
52
+2
| +4% | +$115 | ﹤0.01% | 6678 |
|
2022
Q1 | $7K | Sell |
50
-10
| -17% | -$1.4K | ﹤0.01% | 6284 |
|
2021
Q4 | $10K | Buy |
60
+11
| +22% | +$1.83K | ﹤0.01% | 6190 |
|
2021
Q3 | $7K | Sell |
49
-30
| -38% | -$4.29K | ﹤0.01% | 6366 |
|
2021
Q2 | $38K | Buy |
79
+1
| +1% | +$481 | ﹤0.01% | 5235 |
|
2021
Q1 | $32K | Buy |
78
+42
| +117% | +$17.2K | ﹤0.01% | 5171 |
|
2020
Q4 | $17K | Sell |
36
-7
| -16% | -$3.31K | ﹤0.01% | 5213 |
|
2020
Q3 | $24K | Sell |
43
-487
| -92% | -$272K | ﹤0.01% | 4798 |
|
2020
Q2 | $51K | Hold |
530
| – | – | ﹤0.01% | 4155 |
|
2020
Q1 | $38K | Buy |
+530
| New | +$38K | ﹤0.01% | 4171 |
|